Chemical Complementation Assay for MKP-3 (RMI)
Chemical Complementation Assay for MKP-3 (RMI)
批准号:
7057143
负责人:
JOHN S. LAZO
金额:
$0.45万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-15 至 2006-09-14
中文摘要
描述(由申请人提供):丝裂原活化蛋白激酶磷酸酶-3 (MKP-3)是一种双特异性磷酸酶,通过控制丝裂原活化蛋白激酶的磷酸化状态来调节细胞内信号转导。有大量证据表明MKP-3可能是几种人类疾病的潜在分子靶点。然而,目前还没有发现这种蛋白磷酸酶的有效或选择性的小分子抑制剂。基于细胞的化学互补分析为筛选这种蛋白磷酸酶的细胞活性抑制剂提供了一种新的平台技术。该提案将提供足够的试剂,包括细胞和DMA转染载体,以允许高通量筛选100,000种化合物。
英文摘要
DESCRIPTION (provided by applicant): Mitogen activated protein kinase phosphatase-3 (MKP-3) is a dual specificity phosphatase that has a central role regulating intracellular signal transduction by controlling the phosphorylation status of mitogen activated protein kinases. There is considerable evidence indicating MKP-3 could be a potential molecular target for several human diseases. Nonetheless, no potent or selective small molecule inhibitors of this protein phosphatase have been identified. Cell-based chemical complementation assays provide a novel platform technology to screen for cell-active inhibitors of this protein phosphatase. This proposal will provide sufficient reagents, including cells and DMA transfection vectors, to permit the high throughput screening of 100,000 compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10632154
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2022
-
负责人:JOHN S. LAZO
-
依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10330408
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2021
-
负责人:JOHN S. LAZO
-
依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10540550
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2021
-
负责人:JOHN S. LAZO
-
依托单位:
Developing small molecule PTP4A3 inhibitors for ovarian cancer
-
批准号:9769367
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2019
-
负责人:JOHN S. LAZO
-
依托单位:
Operetta CLS High-content Imaging System
-
批准号:9274679
-
项目类别:
-
资助金额:$51.6万
-
财政年份:2017
-
负责人:JOHN S. LAZO
-
依托单位:
PTP4A3 as a Molecular Cancer Target
-
批准号:8814295
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2014
-
负责人:JOHN S. LAZO
-
依托单位:
CHEMICAL BIOLOGY FACILITY
-
批准号:8181010
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2010
-
负责人:JOHN S. LAZO
-
依托单位:
siRNA Library Screening for Pharmacologic Radiation Mitigators
-
批准号:8010798
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2010
-
负责人:JOHN S. LAZO
-
依托单位:
In Vitro High Throughput Screening Assay for MKP-3(RMI)
-
批准号:7058166
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7076269
-
项目类别:
-
资助金额:$334.7万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7691436
-
项目类别:
-
资助金额:$75.75万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7231271
-
项目类别:
-
资助金额:$1.99万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
In Vitro High Throughput Screening Assay for MKP-1(RMI)
-
批准号:7058173
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7277157
-
项目类别:
-
资助金额:$372.19万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7502274
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Core--Medicinal chemistry: discovery and screening
-
批准号:7055205
-
项目类别:
-
资助金额:$18.42万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
CANCER STRESS RELEVANT PROTEIN PHOSPHATASE TARGETS
-
批准号:6923496
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Chemical Complementation Assay for MKP-1 (RMI)
-
批准号:7058509
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
MOLECULAR PHARM. AND BIOCHEM. OF NOVEL DUAL SPECIIFICITY PHOSPHATASE INHIBITORS
-
批准号:6928832
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:6950645
-
项目类别:
-
资助金额:$205.79万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位: